KoBioLabs, Inc (KOSDAQ:348150)
 4,955.00
 -45.00 (-0.90%)
  Last updated: Oct 30, 2025, 9:59 AM KST
KoBioLabs Company Description
KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and neurological diseases. The company is based in Seongnam-si, South Korea.
KoBioLabs, Inc
  | Country | South Korea | 
| Industry | Biological Products, Except Diagnostic Substances | 
| CEO | GwangPyo Ko | 
Contact Details
| Address: Building C Seongnam-si, 13488 South Korea | |
| Phone | 82 2 888 9964 | 
| Website | kobiolabs.com | 
Stock Details
| Ticker Symbol | 348150 | 
| Exchange | KOSDAQ | 
| Fiscal Year | January - December | 
| Reporting Currency | KRW | 
| SIC Code | 2836 | 
Key Executives
| Name | Position | 
|---|---|
| GwangPyo Ko | Chief Executive Officer | 
| Hyunkyu Lim | Chief Financial Officer | 
| Han Seung Lee | Chief Operating Officer |